Paul Tudor Jones Molecular Partners Ag Transaction History

Tudor Investment Corp Et Al

  • $44 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$16.51 - $31.89 $247,749 - $478,541
-15,006 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$9.99 - $20.49 $1.58 Million - $3.24 Million
-158,000 Reduced 91.33%
15,006 $288,000
Q3 2021

Nov 15, 2021
SELL
$18.34 - $21.0 $37,175 - $42,567
-2,027 Reduced 1.16%
173,006 $3.39 Million
Q2 2021

Aug 16, 2021
BUY
$19.25 - $21.01 $3.37 Million - $3.68 Million
175,033 New
175,033 $3.59 Million

Others Institutions Holding MOLN

# of Institutions
7
Shares Held
3.59M
Call Options Held
0
Put Options Held
0
View Full List

About MOLECULAR PARTNERS AG

MOLN Quotes by TradingView
  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $114M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email